Literature DB >> 29357955

Demographics of a large paediatric Postural Orthostatic Tachycardia Syndrome Program.

Jeffrey R Boris1, Thomas Bernadzikowski2.   

Abstract

OBJECTIVE: The aim of this study was to identify and evaluate demographic and clinical features of paediatric patients with postural orthostatic tachycardia syndrome in a tertiary hospital speciality clinic.
METHOD: This is a retrospective review of clinical data obtained during initial outpatient evaluation.
RESULTS: A total of 708 patients met the evaluation criteria. Female patients outnumbered males, 3.45:1. Caucasians were over-represented at 94.1% of patients. Median age at diagnosis was 15.7 years. Joint hypermobility occurred in 57.3% of patients; 22.4% had hypermobile Ehlers-Danlos syndrome; and 34.9% had hypermobility spectrum disorder. Median age of onset of symptoms was 12.6 years in patients with hypermobility versus 13.7 years in those without (p=0.0001). Median duration of symptoms was 3.3 years with hypermobility versus 1.5 years without (p<0.00001). Putative triggers included infection in 23.6% of patients, concussion in 11.4%, and surgery/trauma in 2.8%. Concurrent inflammatory disorders were noted in 5.2% of patients. Six symptoms comprised 80% of initial patient complaints. Overall, 66% of patients subsequently had at least 10 symptoms, 50% had at least 14 symptoms, and 30% reported at least 26 symptoms. Symptoms were largely cardiovascular, gastrointestinal, and neurological. Paediatric patients with postural orthostatic tachycardia syndrome seen in a large speciality clinic are predominantly female, are mostly Caucasian, have onset of symptoms in early adolescence, and have symptoms for over two years before diagnosis. Over half of patients have joint hypermobility. More than one-third of patients have a possible autoimmune or inflammatory trigger, including infection, concussion, or surgery/trauma. Patients experience symptoms that are highly variable and multi-system in origin over the course of illness.

Entities:  

Keywords:  Ehlers–Danlos; autoimmune; concussion; dysautonomia; joint hypermobility

Mesh:

Year:  2018        PMID: 29357955     DOI: 10.1017/S1047951117002888

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  18 in total

1.  Attention and executive function are impaired during active standing in postural tachycardia syndrome.

Authors:  Amanda J Miller; Timothy Sheehan; Kate M Bourne; Monica Feeley; Amy C Arnold
Journal:  Auton Neurosci       Date:  2020-06-06       Impact factor: 3.145

Review 2.  Pathophysiology and Individualized Management of Vasovagal Syncope and Postural Tachycardia Syndrome in Children and Adolescents: An Update.

Authors:  Ying Liao; Junbao Du
Journal:  Neurosci Bull       Date:  2020-05-04       Impact factor: 5.203

Review 3.  Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.

Authors:  Adena Zadourian; Taylor A Doherty; Iwona Swiatkiewicz; Pam R Taub
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

4.  Orthostatic heart rate does not predict symptomatic burden in pediatric patients with chronic orthostatic intolerance.

Authors:  Jeffrey R Boris; Jing Huang; Thomas Bernadzikowski
Journal:  Clin Auton Res       Date:  2019-08-05       Impact factor: 4.435

5.  Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.

Authors:  Amanda J Miller; Lauren E Stiles; Timothy Sheehan; Rebecca Bascom; Howard P Levy; Clair A Francomano; Amy C Arnold
Journal:  Auton Neurosci       Date:  2020-01-10       Impact factor: 3.145

Review 6.  Pain Management In Pediatric Patients With Postural Orthostatic Tachycardia Syndrome: Current Insights.

Authors:  Ashley N Junghans-Rutelonis; Andrea Postier; Andrew Warmuth; Scott Schwantes; Karen E Weiss
Journal:  J Pain Res       Date:  2019-10-31       Impact factor: 3.133

Review 7.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

8.  Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.

Authors:  Steven Vernino; Kate M Bourne; Lauren E Stiles; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Andre Diedrich; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Anil Darbari; Satish R Raj
Journal:  Auton Neurosci       Date:  2021-06-05       Impact factor: 2.355

Review 9.  Activity and Exercise Intolerance After Concussion: Identification and Management of Postural Orthostatic Tachycardia Syndrome.

Authors:  Nicole A Miranda; Jeffrey R Boris; Kristen M Kouvel; Lauren Stiles
Journal:  J Neurol Phys Ther       Date:  2018-07       Impact factor: 3.649

Review 10.  Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.

Authors:  Faryal Tahir; Taha Bin Arif; Zainab Majid; Jawad Ahmed; Muhammad Khalid
Journal:  Cureus       Date:  2020-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.